These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33505148)

  • 1. Human hepatitis viruses-associated cutaneous and systemic vasculitis.
    Wang CR; Tsai HW
    World J Gastroenterol; 2021 Jan; 27(1):19-36. PubMed ID: 33505148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis.
    Sharma A; Sharma K
    J Clin Exp Hepatol; 2013 Sep; 3(3):204-12. PubMed ID: 25755502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasculitis and liver disease].
    Spangenberg HC; Blum HE
    Praxis (Bern 1994); 2006 Oct; 95(40):1557-62. PubMed ID: 17048414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Viral vasculitis not related to HBV, HCV and HIV].
    Lortholary O; Généreau T; Guillevin I
    Pathol Biol (Paris); 1999 Mar; 47(3):248-51. PubMed ID: 10214617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatologic manifestations of Hepatitis C Virus.
    Treppo E; Quartuccio L; Ragab G; DE Vita S
    Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasculitis related to viral and other microbial agents.
    Teng GG; Chatham WW
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):226-43. PubMed ID: 26362741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic manifestations in chronic hepatitis C virus carriers.
    Rosenthal E; Cacoub P
    Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Agnello V
    Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of viral vasculitis].
    Lhote F; Guillevin L
    Pathol Biol (Paris); 1999 Mar; 47(3):257-64. PubMed ID: 10214619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection].
    Retamozo S; Brito-Zerón P; Ramos-Casals M
    Med Clin (Barc); 2015 May; 144(9):410-7. PubMed ID: 24787686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extrahepatic manifestations of HBV and HCV infection].
    Hartmann H
    Praxis (Bern 1994); 1997 Jul; 86(29-30):1163-6. PubMed ID: 9333915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
    Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
    Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC).
    Mazzaro C; Dal Maso L; Gragnani L; Visentini M; Saccardo F; Filippini D; Andreone P; Zignego AL; Gattei V; Monti G; Galli M; Quartuccio L
    Viruses; 2021 May; 13(6):. PubMed ID: 34070832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
    Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection.
    Buezo GF; García-Buey M; Rios-Buceta L; Borque MJ; Aragües M; Daudén E
    Int J Dermatol; 1996 Feb; 35(2):112-5. PubMed ID: 8850039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoglobulinemic vasculitis.
    Ferri C; Mascia MT
    Curr Opin Rheumatol; 2006 Jan; 18(1):54-63. PubMed ID: 16344620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease.
    Sharma P; Sawtell R; Wang Q; Sise ME
    Adv Kidney Dis Health; 2023 Jul; 30(4):343-355. PubMed ID: 37657881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review.
    Mazzaro C; Dal Maso L; Visentini M; Gitto S; Andreone P; Toffolutti F; Gattei V
    J Intern Med; 2019 Sep; 286(3):290-298. PubMed ID: 31124596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
    Landau DA; Scerra S; Sene D; Resche-Rigon M; Saadoun D; Cacoub P
    J Rheumatol; 2010 Mar; 37(3):615-21. PubMed ID: 20110523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.